Post-market surveillance (PMS) is complex and often misunderstood by device manufacturers. Europe's new Medical Devices Regulation (MDR) adds to the complexity of complying with specific PMS and post-market clinical follow-up (PMCF) requirements. Many companies will need to maintain more robust PMS procedures and perform more PMCF studies to meet their Notified Body’s expectations. In this free webinar, we will discuss new European PMS and PMCF requirements.
What will you learn:
ABOUT THE PRESENTER:
Ronald Boumans is a Senior Regulatory Consultant at Emergo's office in The Hague with 30+ years of experience in the medical device industry. Prior to joining Emergo, he served as Inspector of Medical Technology at the Dutch Healthcare Inspectorate (IGZ). Ronald’s expertise includes European medical device legislation, Competent Authority supervision, and CE Marking requirements. He is a member of the EUDAMED Steering Committee and the EUDAMED post-market surveillance, vigilance, and data exchange working groups.
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多近年来,巴西医疗器械监管当局ANVISA频频发布新规,以求促进巴西当地医疗器械市场发展。目前巴西医疗器械上市监管环境逐渐透明化,随着新法规的不断出台及更新,许多欲开拓出海市场的医疗器械企业正把巴西作为主要目标市场之一。 然而,相较于全球诸多医疗器械市场监管环境而言,巴西市场目前仍
阅读更多